Literature DB >> 22398595

Companies in rapid pursuit of Btk immunokinase.

Cormac Sheridan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398595     DOI: 10.1038/nbt0312-199

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  The many faces of Bruton's tyrosine kinase.

Authors:  C Patrick McAtee
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

2.  Imbruvica--next big drug in B-cell cancer--approved by FDA.

Authors:  Malini Guha
Journal:  Nat Biotechnol       Date:  2014-02       Impact factor: 54.908

3.  Cell biology: a key driver of therapeutic innovation.

Authors:  Oliver Hantschel; Giulio Superti-Furga
Journal:  J Cell Biol       Date:  2012-11-12       Impact factor: 10.539

Review 4.  Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Authors:  Vinayak Palve; Yi Liao; Lily L Remsing Rix; Uwe Rix
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.